Gissel Yobreli

Residente de Oncología. Especialista en Medicina Interna

[Toni Choueiri, MD @DrChoueiri]

Recent @Nature analysis shows the breakdown of cancer-related publications in the and reveals the cancer types with the highest output, and the leaders of the field.

📊 Breast cancer remains the most-studied cancer globally in the Nature Index (2021–2025), well ahead of lung cancer.

🌍 The 🇺🇸 and 🇨🇳 together contribute ~60% of global cancer research output in the Nature Index.

🏛️ @Harvard is the world’s leading institutional contributor, followed by the Chinese Academy of Sciences @CAS__Science and @NIH

🎯 Countries with the strongest cancer research focus relative to their overall scientific output include the 🇺🇸 🇳🇱 🇸🇬 🇨🇦 🇹🇼 .

[Enrique Grande @drenriquegrande]

⚡️ Histological subtypes of urothelial carcinoma — micropapillary, plasmacytoid, sarcomatoid, squamous — don't fit the one-size-fits-all treatment paradigm.

Each carries distinct biology, is often understaged on TURBT, and shows variable response to standard systemic therapy.

https://t.co/NnF32TmzJn

#BladderCancer

[Oncology Brothers @OncBrothers]

This is the current treatment landscape and recent data around HERIZON-GEA-01 for Her2 GEJ/Gastric Cancer that we touched on with @SunnieSKim and @Sam_Cytryn

#OncTwitter #Oncology #gism @gotoPER

[JAMA Otolaryngology – Head & Neck Surgery @JAMAOto]

Neoadjuvant chemoimmunotherapy for resectable locoregionally advanced head and neck squamous cell carcinoma (#HNSCC) was associated with higher rates of major and complete pathologic response compared with immunotherapy alone.

https://t.co/RCGD0RWJE2

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

Different Diseases, Different Escapes: Trastuzumab Deruxtecan Resistance in HER2-Amplified versus HER2-Low #BreastCancer
👉https://t.co/nIXkLNAe3C
@tess_omeara @PTarantinoMD

[UroToday.com @urotoday]

Optimizing patient selection for radioligand therapy in advanced stages. Presentation by @ProfKHerrmann. #ESMO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/bUxnTGK0Xv @myESMO

[Virginio Gallardo @virginiog]

Escribir a mano protege el cerebro, según un estudio de la Universidad de Indiana
Mover el lápiz genera una mayor conectividad neuronal, a diferencia del teclado
La clave no es rechazar la tecnología, sino usarla de forma equilibrada para potenciar nuestra mente

[Paolo Tarantino @PTarantinoMD]

The KM curve of 2025 outside of breast oncology. Neoadjuvant EV+pembro more than halved the risk of recurrence and significantly improved OS among platinum-ineligible pts with bladder cancer.

The tremendous power of ADCs + IO, transforming oncology.

#ESMO25 #ESMOAmbassadors

[INCMNSZ @incmnszmx]

* * * CONVOCATORIA * * *
Personal de la Salud para Coordinación de Estudios de Investigación
Servicio de Hepatología y Trasplante Hepático

[Hablemos de Alzheimer y Demencia @TipsCuidadores]

Maltratos en el adulto mayor.

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) and CKD: Are You a #Flozinator? ca. 2023 from @KidneyMed @GlomCon #Nephpearls

👉 https://t.co/mn5ayR8yqs

[Jonathan Chávez @JonathanNefro]

La lesión renal aguda por síndrome de lisis tumoral se explica el efecto patogénico que ejercen los cristales de fosfato de calcio, de hipoxantina, ácido úrico y xantina derivados de la destrucción masiva del cancer sobre la nefrona

Nature Primers 2024
10.1038/s41572-024-00542-w

[Oren Gottfried, MD @OGdukeneurosurg]

Lung problems

[soria @jsoriamd]

Frequency of HER2 alterations across tumor types & current development landscape of HER2-targeted therapies summarized in this publication.
https://t.co/opxohzidRu

[Jorge Alatorre Alexander @JorgeAlatorreA1]

Se fortalece el programa de Screening de Cáncer de pulmón en el @RespiraINER para personas que fuman ( o fumaron ) mayores a 50 años

[Gissel Yobreli @yobreli]

@montserdze Confirmo

[Montserrat @montserdze]

Este doctor básicamente hizo varios de estos hasta quitar la lesión completa 🤡.

No nos caen mal por poner toxina botulínica, nos molestan los que creen que pueden ver patologías de piel para las que no estudiaron.

[Chema Fernandez @chemachir]

🆕SELECT : Semaglutide 2.4 mg en IMC>= 27kg/m2 no DM VS placebo.
✅🚻17604 y ⏱️ 34.2 meses
✅⬇️20% MACÉ
✅⬇️19%☠️total
✅⬇️18% 🏥IC.
https://t.co/8ITCJLZ2UB
@Diabetes_SEMI @IcyfaSemi @MedicinaSAM @CarreteroJuani @fjcarrascos @joscarlor2 @pedropabloce @FormigaFrancesc @jopesilver

[Gissel Yobreli @yobreli]

@Abraham_RMI @emmanuel2008 @HervertPedraza Muchas felicidades Doctor 🎊 que gusto saber que ya está aprobado 😊

[DrSamShuaibi @drsamshuaibi]

Can you guess what this is?🤔🤔

Best answer will be noted👏🏻🥰
#Usmle #DrSam👩🏼‍⚕️🩺 #medtwitter #match2024 #match2023 #ecfmg #ecfmgcertificate